Learn more about Peter Attia’s digital program
#289 – AMA #56: Cancer screening: pros and cons, screening options, interpreting results, and more
“There has been a pretty clear and consistent benefit [to cancer screening] that has been demonstrated, and the exceptions I think have a pretty clear sense of why.” —Peter Attia
#286 ‒ Journal club with Andrew Huberman: the impact of light exposure on mental health and an immunotherapy breakthrough for cancer treatment
“People spend 90% of their time indoors now. Their daytime environments are too dim, their nighttime environments are too bright.” —Andrew Huberman
The futility of estimating changes to all-cause mortality from target cancer screening studies
Why a recent publication shouldn’t change your motivation to get screened for cancer
#278 ‒ Breast cancer: how to catch, treat, and survive breast cancer | Harold Burstein, M.D., Ph.D.
“We’ve completely flipped the outcomes for HER2-positive breast cancer, where it has gone from one of the most feared types of breast cancer to one of the most successfully treated types of breast cancer.” —Harold Burstein
#275 – AMA #52: Hormone replacement therapy: practical applications and the role of compounding pharmacies
“The sum total of lives that have been saved due to less breast cancer as a result from the lack of HRT for the past 20 years is exactly zero.” —Peter Attia
Can a peptide found in bee stings offer hope for treatment-resistant breast cancers?
Melittin, the main component of honeybee venom, has shown promise as a basis for chemotherapeutic drugs to combat treatment-resistant breast cancer
#268 ‒ Genetics: testing, therapy, editing, association with disease risk, autism, and more | Wendy Chung, M.D., Ph.D.
“There are literally tens of thousands of genetic variants in your genome, and what they mean and whether or not they do anything whatsoever is hard to know.” —Wendy Chung
#267 ‒ The latest in cancer therapeutics, diagnostics, and early detection | Keith Flaherty, M.D.
“Early detection is going to allow our same toolbox of drugs to be massively more effective.” —Keith Flaherty
#253 ‒ Hormone replacement therapy and the Women’s Health Initiative: re-examining the results, the link to breast cancer, and weighing the risk vs reward of HRT | JoAnn Manson, M.D.
“It’s so important for women to understand that the absolute risks of these hormones are much lower in early menopause than in later menopause.” —JoAnn Manson
How failures in study selection can sink a meta-analysis
Mixing apples and oranges and winding up with garbage